Targeted Brain Delivery of Therapeutics
Ready for Clinical Application
TXP1
Brain Shuttle
Based on the Deimmunised VNAR Antibody Scaffold and Targeting TfR1 for Efficient Receptor Mediated Transcytosis Across the Blood-Brain Barrier
Delivery of Therapeutics Across the Blood-Brain Barrier Presents New Opportunities for the Next Generation of CNS Therapies
Following the Science
Board of Directors
Experience and Skill
Our Partners
Disclaimer
All Rights Reserved | Ossianix